UA99828C2 - Прямое растворение доцетаксела в растворителе полисорбате 80 - Google Patents
Прямое растворение доцетаксела в растворителе полисорбате 80Info
- Publication number
- UA99828C2 UA99828C2 UAA200913326A UAA200913326A UA99828C2 UA 99828 C2 UA99828 C2 UA 99828C2 UA A200913326 A UAA200913326 A UA A200913326A UA A200913326 A UAA200913326 A UA A200913326A UA 99828 C2 UA99828 C2 UA 99828C2
- Authority
- UA
- Ukraine
- Prior art keywords
- solvent
- docetaxel
- polysorbate
- direct dissolution
- dissolution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Epoxy Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Изобретение касается растворения доцетаксела в органическом растворителе, его смешивания с полисорбатом 80 и выпаривания растворителя.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0704095A FR2917088B1 (fr) | 2007-06-08 | 2007-06-08 | Dissolution directe du docetaxel dans un solvant dans le polysorbate 80 |
Publications (1)
Publication Number | Publication Date |
---|---|
UA99828C2 true UA99828C2 (ru) | 2012-10-10 |
Family
ID=39048780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200913326A UA99828C2 (ru) | 2007-06-08 | 2008-06-06 | Прямое растворение доцетаксела в растворителе полисорбате 80 |
Country Status (32)
Country | Link |
---|---|
US (1) | US20100197776A1 (ru) |
EP (1) | EP2155189A2 (ru) |
JP (1) | JP2010529094A (ru) |
KR (1) | KR20100022033A (ru) |
CN (2) | CN102908309A (ru) |
AR (1) | AR066889A1 (ru) |
AU (1) | AU2008270141A1 (ru) |
BR (1) | BRPI0812438A2 (ru) |
CA (1) | CA2689466A1 (ru) |
CL (1) | CL2008001650A1 (ru) |
CO (1) | CO6260063A2 (ru) |
CR (1) | CR11144A (ru) |
DO (1) | DOP2009000249A (ru) |
EA (1) | EA200971137A1 (ru) |
EC (1) | ECSP099789A (ru) |
FR (1) | FR2917088B1 (ru) |
GT (1) | GT200900306A (ru) |
HN (1) | HN2009003363A (ru) |
IL (1) | IL202517A0 (ru) |
MA (1) | MA31671B1 (ru) |
MX (1) | MX2009013216A (ru) |
MY (1) | MY151417A (ru) |
NI (1) | NI200900209A (ru) |
NZ (1) | NZ581634A (ru) |
PA (1) | PA8783101A1 (ru) |
SV (1) | SV2009003428A (ru) |
TN (1) | TN2009000396A1 (ru) |
TW (1) | TW200916095A (ru) |
UA (1) | UA99828C2 (ru) |
UY (1) | UY31129A1 (ru) |
WO (1) | WO2009004188A2 (ru) |
ZA (1) | ZA200908662B (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011139899A2 (en) | 2010-05-03 | 2011-11-10 | Teikoku Pharma Usa, Inc. | Non-aqueous taxane pro-emulsion formulations and methods of making and using the same |
JO3685B1 (ar) | 2012-10-01 | 2020-08-27 | Teikoku Pharma Usa Inc | صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2678833B1 (fr) * | 1991-07-08 | 1995-04-07 | Rhone Poulenc Rorer Sa | Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes. |
US6040330A (en) * | 1999-01-08 | 2000-03-21 | Bionumerik Pharmaceuticals, Inc. | Pharmaceutical formulations of taxanes |
GB9920548D0 (en) * | 1999-08-31 | 1999-11-03 | Rhone Poulenc Rorer Sa | Treatment of hepatocellular carcinoma |
US20020041898A1 (en) * | 2000-01-05 | 2002-04-11 | Unger Evan C. | Novel targeted delivery systems for bioactive agents |
US6838569B2 (en) * | 2002-12-16 | 2005-01-04 | Dabur India Limited | Process for preparation of paclitaxel trihydrate and docetaxel trihydrate |
JPWO2006057429A1 (ja) * | 2004-11-24 | 2008-06-05 | ナノキャリア株式会社 | ブロックコポリマーのモーフォロジーの変化方法 |
BRPI0600194A (pt) * | 2006-01-30 | 2007-10-23 | Quiral Quimica Do Brasil S A | composições farmacêuticas contendo docetaxel e um inibidor de degradação e processo de obtenção das mesmas |
-
2007
- 2007-06-08 FR FR0704095A patent/FR2917088B1/fr not_active Expired - Fee Related
-
2008
- 2008-06-05 CL CL2008001650A patent/CL2008001650A1/es unknown
- 2008-06-06 EP EP08805654A patent/EP2155189A2/fr not_active Withdrawn
- 2008-06-06 TW TW097121332A patent/TW200916095A/zh unknown
- 2008-06-06 AR ARP080102412A patent/AR066889A1/es not_active Application Discontinuation
- 2008-06-06 NZ NZ581634A patent/NZ581634A/en not_active IP Right Cessation
- 2008-06-06 WO PCT/FR2008/000766 patent/WO2009004188A2/fr active Application Filing
- 2008-06-06 CN CN2012103564971A patent/CN102908309A/zh active Pending
- 2008-06-06 MX MX2009013216A patent/MX2009013216A/es not_active Application Discontinuation
- 2008-06-06 CN CN200880019286A patent/CN101677986A/zh active Pending
- 2008-06-06 UA UAA200913326A patent/UA99828C2/ru unknown
- 2008-06-06 AU AU2008270141A patent/AU2008270141A1/en not_active Abandoned
- 2008-06-06 PA PA20088783101A patent/PA8783101A1/es unknown
- 2008-06-06 CA CA002689466A patent/CA2689466A1/fr not_active Abandoned
- 2008-06-06 BR BRPI0812438-8A2A patent/BRPI0812438A2/pt not_active IP Right Cessation
- 2008-06-06 KR KR1020097025515A patent/KR20100022033A/ko not_active Application Discontinuation
- 2008-06-06 UY UY31129A patent/UY31129A1/es unknown
- 2008-06-06 JP JP2010510844A patent/JP2010529094A/ja active Pending
- 2008-06-06 MY MYPI20095154 patent/MY151417A/en unknown
- 2008-06-06 EA EA200971137A patent/EA200971137A1/ru unknown
-
2009
- 2009-09-30 TN TNP2009000396A patent/TN2009000396A1/fr unknown
- 2009-10-22 DO DO2009000249A patent/DOP2009000249A/es unknown
- 2009-10-28 CO CO09121683A patent/CO6260063A2/es active IP Right Grant
- 2009-11-23 US US12/623,547 patent/US20100197776A1/en not_active Abandoned
- 2009-11-26 GT GT200900306A patent/GT200900306A/es unknown
- 2009-12-03 NI NI200900209A patent/NI200900209A/es unknown
- 2009-12-03 IL IL202517A patent/IL202517A0/en unknown
- 2009-12-03 CR CR11144A patent/CR11144A/es not_active Application Discontinuation
- 2009-12-03 SV SV2009003428A patent/SV2009003428A/es not_active Application Discontinuation
- 2009-12-07 ZA ZA2009/08662A patent/ZA200908662B/en unknown
- 2009-12-07 HN HN2009003363A patent/HN2009003363A/es unknown
- 2009-12-08 EC EC2009009789A patent/ECSP099789A/es unknown
-
2010
- 2010-01-07 MA MA32495A patent/MA31671B1/fr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2007000311A1 (es) | Compuestos derivados de cromen-2-ona; composicion farmaceutica que los comprende;y su uso en el trastamiento de un trastorno proliferativos como es el cancer. | |
CL2007003552A1 (es) | Compuestos derivados de pirimidina y piridina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de un trastorno proliferativo celular. | |
CL2007002682A1 (es) | Compuestos derivados de 4-metilpiridopirimidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar el crecimiento anormal de celulas, como cancer. | |
TW200740956A (en) | Organic electroluminescent devices | |
CL2007002167A1 (es) | Compuestos derivados de indol, antagonistas iap; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de cancer. | |
HN2008001720A (es) | Arilimidazolonas y ariltriazolonas sustituidas como inihibidores de receptores de vasopresina | |
CL2007001902A1 (es) | Compuestos derivados de piridina sustituidas; composicion farmaceutica; y uso en el tratamiento de un trastorno de agregacion de plaquetas. | |
CL2007002996A1 (es) | Compuestos derivados de quinolina sustituido, moduladores de los receptores x del higado; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como sindrome coronario agudo, alzheimer, diabetes y aterosclerosis. | |
CL2007003722A1 (es) | Compuestos derivados de propionamida n-sustituida por heterociclo, activadores de glucoquinasa; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento o prevencion de la diabetes. | |
TW200735438A (en) | Organic electroluminescent devices | |
FR2913358B1 (fr) | Dispositif d'allumage d'une composition aluminothermique, creuset l'incorporant et procedes associes. | |
CL2008000304A1 (es) | Compuestos derivados de 1-oxa-3-azaespiro[4.5]decan-2-ona; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de un trastorno de la alimentacion, obesidad, depresion. | |
MX280211B (es) | Polimero, un metodo para producir el polimero y una mezcla de cemento que utiliza el mismo. | |
EP2213639A4 (en) | MONOBENZOCHRYSEN DERIVAT, THIS CONTAINING MATERIAL FOR ORGANIC ELECTROLUMINESCENZIA DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE WITH THE MATERIAL FOR ORGANIC ELECTROLUMINESCENZIA | |
CL2007003672A1 (es) | Compuestos derivados de heteroaril-pirrolidinil-cetona y heteroaril-piperidinil-cetona; composicion farmaceutica; y uso en el tratamiento de la depresion y ansiedad. | |
CL2014003525A1 (es) | Composicion farmaceutica que comprende fimasartan, hidroclorotiazida y un aglutinante; procedimiento de preparacion; su uso en el tratamiento de hipertension. | |
EP2173141A4 (en) | ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY DEVICE USING THE DEVICE | |
EP2004774A4 (en) | ORGANIC ELECTROLUMINESCENSE COMPOUNDS AND DISPLAYING DEVICE THEREOF | |
CL2009000665A1 (es) | Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas. | |
CL2007003847A1 (es) | Compuestos derivados de pirimidinas 2,4,5 tri-sustituidas; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento del cancer. | |
MY151417A (en) | Direct dissolution of docetaxel in a solvent in polysorbate 80 | |
BRPI0821666A2 (pt) | Derivados 19-nor-esteroides com um grupo 15alfa, 16alfa-metileno e um anel 17, 17-espirolactona saturado, uso deste e produtos medicinais contendo esses derivados | |
CL2012000355A1 (es) | Compuestos derivados de 4-amino-butenamida; composicion farmaceutica; y uso en el tratamiento de la epoc. | |
CL2009000317A1 (es) | Compuestos derivados de 3-alquil-piperazina sustituida; composicion farmaceutica; y su uso en el tratamiento de la depresion y ansiedad. | |
ZA201005396B (en) | 17-hydroxy-19-nor-21-carboxylic acid-steroid y-lactone derivative,use thereof,and medicament containing the derivative |